Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
Hostname: page-component-ffbbcc459-l9rg9 Total loading time: 0.197 Render date: 2022-03-10T02:56:25.136Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }
  • English
The Journal of Laryngology & Otology The Journal of Laryngology & Otology

Article contents

Intensity-modulated radiotherapy (55 Gy in 20 fractions) for high-grade laryngeal dysplasia: report of acute toxicity and functional outcome

Published online by Cambridge University Press:  22 February 2019

J Kovarik ,
M Bhabra ,
A W Tin ,
G Shaikh  and
M S Iqbal
J Kovarik
Affiliation:
Department of Clinical Oncology, Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK
M Bhabra
Affiliation:
ENT Department, Sunderland Royal Hospital, UK
A W Tin
Affiliation:
Department of Clinical Oncology, Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK
G Shaikh
Affiliation:
Department of Clinical Oncology, Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK
M S Iqbal*
Affiliation:
Department of Clinical Oncology, Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK
*
Author for correspondence: Dr Muhammad Shahid Iqbal, Department of Clinical Oncology, Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK E-mail: Shahid.iqbal@nhs.net
Get access Rights & Permissions[Opens in a new window]

Abstract

Objective

Radiotherapy is an option to treat high-grade laryngeal dysplasia. This study aimed to evaluate the use of intensity-modulated radiotherapy, 55 Gy in 20 daily fractions, in treating this disease.

Methods

Acute toxicity was evaluated in all 14 patients treated. In 10 patients, functional voice outcome was measured using the Voice Handicap Index, and the Grade, Roughness, Breath, Asthenia, Strain (‘GRBAS’) scale. These measurements were performed pre-treatment and three months after intensity-modulated radiotherapy.

Results

All but one patient managed to complete radiotherapy. Acute toxicity was significant (one patient developed grade 4 and three patients developed grade 3 dysphagia). Four patients required hospital admission. In 9 out of 10 patients, radiotherapy improved voice quality.

Conclusion

This radiotherapy regimen using intensity-modulated radiotherapy for laryngeal dysplasia is feasible and provided excellent functional outcome, but acute toxicity was significant. Dose de-escalation can be considered in the framework of clinical trials.

Keywords

Intensity-Modulated RadiotherapyLaryngeal Dysplasia
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 133 , Issue 3 , March 2019 , pp. 241 - 244
Copyright
Copyright © JLO (1984) Limited, 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr M S Iqbal takes responsibility for the integrity of the content of the paper

References

1Karatayli-Ozgursoy, S, Pacheco-Lopez, P, Hillel, AT, Best, SR, Bishop, JA, Akst, LM. Laryngeal dysplasia, demographics, and treatment: a single-institution, 20-year review. JAMA Otolaryngol Head Neck Surg 2015;141:313–18CrossRefGoogle ScholarPubMed
2Weller, MD, Nankivell, PC, McConkey, C, Paleri, V, Mehanna, HM. The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta-analysis. Clin Otolaryngol 2010;35:364–72CrossRefGoogle ScholarPubMed
3Mehanna, H, Paleri, V, Robson, A, Wight, R, Helliwell, T. Consensus statement by otorhinolaryngologists and pathologists on the diagnosis and management of laryngeal dysplasia. Clin Otolaryngol 2010;35:170–6CrossRefGoogle ScholarPubMed
4Sadri, M, McMahon, J, Parker, A. Management of laryngeal dysplasia: a review. Eur Arch Otorhinolaryngol 2006;263:843–52CrossRefGoogle ScholarPubMed
5Small, W, Mittal, BB, Brand, WN, Shetty, RM, Rademaker, AW, Beck, GG et al. Role of radiation therapy in the management of carcinoma in situ of the larynx. Laryngoscope 1993;103:663–7CrossRefGoogle ScholarPubMed
6Garcia-Serra, A, Hinerman, RW, Amdur, RJ, Morris, CG, Mendenhall, WM. Radiotherapy for carcinoma in situ of the true vocal cords. Head Neck 2002;24:390–4CrossRefGoogle ScholarPubMed
7Le, QT, Takamiya, R, Shu, HK, Smitt, M, Singer, M, Terris, DJ et al. Treatment results of carcinoma in situ of the glottis: an analysis of 82 cases. Arch Otolaryngol Head Neck Surg 2000;126:1305–12CrossRefGoogle ScholarPubMed
8MacLeod, PM, Daniel, F. The role of radiotherapy in in-situ carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1990;18:113–17CrossRefGoogle ScholarPubMed
9Barnes, L, Eveson, JW, Reichart, P, Sidransky, D, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press, 2005Google Scholar
10Common Terminology Criteria for Adverse Events v4.0. In: https://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5×7.pdf [30 January 2019]Google Scholar
11Rosen, CA, Lee, AS, Osborne, J, Zullo, T, Murry, T. Development and validation of the voice handicap index-10. Laryngoscope 2004;114:1549–56CrossRefGoogle ScholarPubMed
12Arffa, RE, Krishna, P, Gartner-Schmidt, J, Rosen, CA. Normative values for the Voice Handicap Index-10. J Voice 2012;26:462–5CrossRefGoogle ScholarPubMed
13Omori, K. Diagnosis of voice disorders. JMAJ 2011;54:248–53Google Scholar
14De Bodt, MS, Wuyts, FL, Van de Heyning, PH, Croux, C. Test-retest of the GRBAS scale: influence of experience and professional background on perceptual rating of voice quality. J Voice 1997;11:74–80CrossRefGoogle ScholarPubMed
15Rigual, NR, Thankappan, K, Cooper, M, Sullivan, M, Dougherty, T, Popat, SR et al. Photodynamic therapy for head and neck dysplasia and cancer. Arch Otolaryngol Head Neck Surg 2009;135:784–8CrossRefGoogle ScholarPubMed
16Mimikos, C, Shafirstein, G, Arshad, H. Current state and future of photodynamic therapy for the treatment of head and neck squamous cell carcinoma. World J Otorhinolaryngol Head Neck Surg 2016;2:126–9CrossRefGoogle ScholarPubMed
17Huang, G, Luo, M, Zhang, J, Liu, H. The voice quality after laser surgery versus radiotherapy of T1a glottis carcinoma: systematic review and meta-analysis. Onco Targets Ther 2017;10:2403–10CrossRefGoogle ScholarPubMed
18Higgins, KM. What treatment for early-stage glottis carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility? Laryngoscope 2011;121:116–34CrossRefGoogle ScholarPubMed
19Higgins, KM, Shah, MD, Ogaick, MJ, Enepekides, D. Treatment of early-stage glottis cancer: meta-analysis comparison of laser excision versus radiotherapy. J Otolaryngol Head Neck Surg 2009;38:603–12Google ScholarPubMed
20Aaltonen, LM, Rautiainen, N, Sellman, J, Saarilahti, K, Makitie, A, Laranne, J et al. Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy. Int J Radiat Oncol Biol Phys 2014;90:255–60CrossRefGoogle ScholarPubMed
21Greulich, MT, Parker, NP, Lee, P, Merati, AL, Misono, S. Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis. Otolaryngol Head Neck Surg 2015;152:811–19CrossRefGoogle ScholarPubMed

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Intensity-modulated radiotherapy (55 Gy in 20 fractions) for high-grade laryngeal dysplasia: report of acute toxicity and functional outcome
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Intensity-modulated radiotherapy (55 Gy in 20 fractions) for high-grade laryngeal dysplasia: report of acute toxicity and functional outcome
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Intensity-modulated radiotherapy (55 Gy in 20 fractions) for high-grade laryngeal dysplasia: report of acute toxicity and functional outcome
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *